Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Alamercery

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Controlled Clinical Trials|March 1, 1986
Functional equality of coordinating centers in a multicenter clinical trial. Experience of the International Mexiletine and Placebo Antiarrhythmic Coronary Trial (IMPACT)Y Alamercery, P Wilkins, T Karrison
Fundamental & Clinical Pharmacology|January 1, 1991
Do prescribers know the results of key clinical trials? GEP (Groupe d'étude de la Prescription)S Reveilleau, J P Boissel, Y Alamercery
Therapie|November 1, 1990
[Clinical trials in general practice. The telematics solution]J P Boissel, Y Alamercery, J P Collet, et al.
Journal De Pharmacologie|January 1, 1986
[Information systems for phase III and IV clinical trials]Y Alamercery, Begaud, Chastang, et al.
Therapie|November 1, 1996
[Example of a phase IV trial involving several physicians and aiming at answering a scientific question: EOL]J P Boissel, O Meillard, E Perrin-Fayolle, et al.
European Journal of Clinical Pharmacology|January 1, 1996
Comparison between a bid and a tid regimen: improved compliance with no improved antihypertensive effect. The EOL Research GroupJ P Boissel, O Meillard, E Perrin-Fayolle, et al.
The Journal of Clinical Endocrinology and Metabolism|September 1, 1987
Growth hormone (GH) response to a single intravenous injection of synthetic GH-releasing hormone in prepubertal children with growth failureP Chatelain, Y Alamercery, J Blanchard, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|February 12, 2002
New insights into the postnatal growth of infants born 'idiopathic' small for gestational ageP Chatelain, N Peretti, A Lapillonne, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Controlled Clinical Trials|March 1, 1986
Functional equality of coordinating centers in a multicenter clinical trial. Experience of the International Mexiletine and Placebo Antiarrhythmic Coronary Trial (IMPACT)Y Alamercery, P Wilkins, T Karrison
Fundamental & Clinical Pharmacology|January 1, 1991
Do prescribers know the results of key clinical trials? GEP (Groupe d'étude de la Prescription)S Reveilleau, J P Boissel, Y Alamercery
Therapie|November 1, 1990
[Clinical trials in general practice. The telematics solution]J P Boissel, Y Alamercery, J P Collet, et al.
Journal De Pharmacologie|January 1, 1986
[Information systems for phase III and IV clinical trials]Y Alamercery, Begaud, Chastang, et al.
Therapie|November 1, 1996
[Example of a phase IV trial involving several physicians and aiming at answering a scientific question: EOL]J P Boissel, O Meillard, E Perrin-Fayolle, et al.
European Journal of Clinical Pharmacology|January 1, 1996
Comparison between a bid and a tid regimen: improved compliance with no improved antihypertensive effect. The EOL Research GroupJ P Boissel, O Meillard, E Perrin-Fayolle, et al.
The Journal of Clinical Endocrinology and Metabolism|September 1, 1987
Growth hormone (GH) response to a single intravenous injection of synthetic GH-releasing hormone in prepubertal children with growth failureP Chatelain, Y Alamercery, J Blanchard, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|February 12, 2002
New insights into the postnatal growth of infants born 'idiopathic' small for gestational ageP Chatelain, N Peretti, A Lapillonne, et al.
Pageof 1